AAAAAA

   
Results: 1-12 |
Results: 12
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history
Authors: Rebbeck, TR Wang, YT Kantoff, PW Krithivas, K Neuhausen, SL Godwin, AK Daly, MB Narod, SA Brunet, JS Vesprini, D Garber, JE Lynch, HT Weber, BL Brown, M
Citation: Tr. Rebbeck et al., Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history, CANCER RES, 61(14), 2001, pp. 5420-5424
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome
Authors: Foulkes, WD Chappuis, PO Wong, N Brunet, JS Vesprini, D Rozen, F Yuan, ZQ Pollak, MN Kuperstein, G Narod, SA Begin, LR
Citation: Wd. Foulkes et al., Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome, ANN ONCOL, 11(3), 2000, pp. 307-313
Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer
Authors: Chappuis, PO Kapusta, L Begin, LR Wong, N Brunet, JS Narod, SA Slingerland, J Foulkes, WD
Citation: Po. Chappuis et al., Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer, J CL ONCOL, 18(24), 2000, pp. 4045-4052
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
Authors: Narod, SA Brunet, JS Ghadirian, P Robson, M Heimdal, K Neuhausen, SL Stoppa-Lyonnet, D Lerman, C Pasini, B de los Rios, P Weber, B Lynch, H
Citation: Sa. Narod et al., Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study, LANCET, 356(9245), 2000, pp. 1876-1881
Increased risk of head and neck cancer in association with GSTT1 nullizygosity for individuals with low exposure to tobacco
Authors: Hamel, N Karimi, S Hebert-Blouin, MN Brunet, JS Gilfix, B Ghadirian, P Black, MJ Narod, SA Foulkes, WD
Citation: N. Hamel et al., Increased risk of head and neck cancer in association with GSTT1 nullizygosity for individuals with low exposure to tobacco, INT J CANC, 87(3), 2000, pp. 452-454
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer
Authors: Moslehi, R Chu, W Karlan, B Fishman, D Risch, H Fields, A Smotkin, D Ben-David, Y Rosenblatt, J Russo, D Schwartz, P Tung, N Warner, E Rosen, B Friedman, J Brunet, JS Narod, SA
Citation: R. Moslehi et al., BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer, AM J HU GEN, 66(4), 2000, pp. 1259-1272
Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer
Authors: Warner, E Foulkes, W Goodwin, P Meschino, W Blondal, J Paterson, C Ozcelik, H Goss, P Allingham-Hawkins, D Hamel, N Di Prospero, L Contiga, V Serruya, C Klein, M Moslehi, R Honeyford, J Liede, A Glendon, C Brunet, JS Narod, S
Citation: E. Warner et al., Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer, J NAT CANC, 91(14), 1999, pp. 1241-1247
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2
Authors: Jernstrom, H Lerman, C Ghadirian, P Lynch, HT Weber, B Garber, J Daly, M Olopade, OI Foulkes, WD Warner, E Brunet, JS Narod, SA
Citation: H. Jernstrom et al., Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2, LANCET, 354(9193), 1999, pp. 1846-1850
Oral contraceptives and hereditary ovarian cancer - Reply
Authors: Narod, SA Brunet, JS
Citation: Sa. Narod et Js. Brunet, Oral contraceptives and hereditary ovarian cancer - Reply, N ENG J MED, 340(1), 1999, pp. 60-60
The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer
Authors: Yuan, ZQ Begin, LR Wong, N Brunet, JS Trifiro, M Gordon, PH Pinsky, L Foulkes, WD
Citation: Zq. Yuan et al., The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer, BR J CANC, 81(5), 1999, pp. 850-854
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations
Authors: Wang-Gohrke, S Weikel, W Risch, H Vesprini, D Abrahamson, J Lerman, C Godwin, A Moslehi, R Olipade, O Brunet, JS Stickeler, E Kieback, DG Kreienberg, R Weber, B Narod, SA Runnebaum, IB
Citation: S. Wang-gohrke et al., Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations, BR J CANC, 81(1), 1999, pp. 179-183
The importance of a family history of breast cancer in predicting the presence of a BRCA mutation
Authors: Foulkes, WD Brunet, JS Warner, E Goodwin, PJ Meschino, W Narod, SA Goss, PE Glendon, G
Citation: Wd. Foulkes et al., The importance of a family history of breast cancer in predicting the presence of a BRCA mutation, AM J HU GEN, 65(6), 1999, pp. 1776-1779
Risultati: 1-12 |